Quoin Pharmaceuticals Ltd Stock Price Prediction
| QNRX Stock | USD 0.62 0.01 1.59% |
Oversold Vs Overbought
47
Oversold | Overbought |
Using Quoin Pharmaceuticals hype-based prediction, you can estimate the value of Quoin Pharmaceuticals Ltd from the perspective of Quoin Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Quoin Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Quoin because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Quoin Pharmaceuticals after-hype prediction price | USD 0.62 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Quoin |
Quoin Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Quoin Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Quoin Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Quoin Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Quoin Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Quoin Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Quoin Pharmaceuticals' historical news coverage. Quoin Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.03 and 11.45, respectively. We have considered Quoin Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Quoin Pharmaceuticals is out of control at this time. Analysis and calculation of next after-hype price of Quoin Pharmaceuticals is based on 3 months time horizon.
Quoin Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Quoin Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Quoin Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Quoin Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.46 | 10.83 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.62 | 0.62 | 0.00 |
|
Quoin Pharmaceuticals Hype Timeline
Quoin Pharmaceuticals is at this time traded for 0.62. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Quoin is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at 0.46%. %. The volatility of related hype on Quoin Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 0.62. The company has price-to-book ratio of 0.58. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Quoin Pharmaceuticals recorded a loss per share of 3.66. The entity last dividend was issued on the 23rd of October 2019. The firm had 1:12 split on the 18th of July 2023. Given the investment horizon of 90 days the next projected press release will be within a week. Check out Quoin Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Quoin Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Quoin Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Quoin Pharmaceuticals' future price movements. Getting to know how Quoin Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Quoin Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BWV | BWV | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PXMD | PaxMedica, Common Stock | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| REVB | Revelation Biosciences | 0.00 | 0 per month | 0.00 | (0.12) | 8.97 | (7.83) | 34.52 | |
| HILS | Hillstream Biopharma | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| VRAX | Virax Biolabs Group | 0.00 | 0 per month | 0.00 | (0.12) | 9.65 | (12.90) | 61.28 | |
| NRBO | Neurobo Pharmaceuticals | 0.00 | 0 per month | 0.00 | (0.11) | 6.76 | (7.34) | 25.62 | |
| ALLR | Allarity Therapeutics | 0.00 | 0 per month | 0.00 | (0.26) | 10.85 | (16.11) | 41.48 | |
| KRBP | Kiromic Biopharma | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BDRX | Biodexa Pharmaceticals | 0.00 | 0 per month | 0.00 | (0.12) | 11.91 | (17.24) | 97.78 | |
| UNCY | Unicycive Therapeutics | 0.00 | 0 per month | 4.33 | 0.11 | 9.76 | (7.41) | 29.22 | |
| CDIO | Cardio Diagnostics Holdings | 0.00 | 0 per month | 0.00 | (0.05) | 12.00 | (13.16) | 57.04 |
Quoin Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Quoin price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Quoin using various technical indicators. When you analyze Quoin charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Quoin Pharmaceuticals Predictive Indicators
The successful prediction of Quoin Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Quoin Pharmaceuticals Ltd, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Quoin Pharmaceuticals based on analysis of Quoin Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Quoin Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Quoin Pharmaceuticals's related companies.
Story Coverage note for Quoin Pharmaceuticals
The number of cover stories for Quoin Pharmaceuticals depends on current market conditions and Quoin Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Quoin Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Quoin Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Quoin Pharmaceuticals Short Properties
Quoin Pharmaceuticals' future price predictability will typically decrease when Quoin Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Quoin Pharmaceuticals Ltd often depends not only on the future outlook of the potential Quoin Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Quoin Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 900.9 K | |
| Cash And Short Term Investments | 10.7 M |
Additional Tools for Quoin Stock Analysis
When running Quoin Pharmaceuticals' price analysis, check to measure Quoin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quoin Pharmaceuticals is operating at the current time. Most of Quoin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Quoin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quoin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Quoin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.